Why the exact diagnosis must be settled before any follow-up discussion
Lymphoma is not one disease. The National Cancer Institute notes that lymphoma includes Hodgkin and non-Hodgkin types, and that the exact diagnosis matters when treatment is discussed. That distinction is the starting point for follow-up planning too. A pathology report that says only 'lymphoma' leaves the receiving clinician unable to judge which surveillance schedule, which late-effect checks or which imaging history is relevant.
If you are already in remission and seeking follow-up in China, the first document to locate is the original pathology report, including the specific Hodgkin lymphoma subtype and any immunohistochemistry or molecular studies that supported it. If the original slides or blocks are available, ask whether the receiving hospital wants them for its own pathology review. That is a question for the hospital, not an assumption you should make in advance.
If the diagnosis is still being confirmed, a follow-up planning article is premature. The immediate question is diagnostic confirmation, not long-term surveillance. In that situation, ask your current treating team what is still outstanding before you approach any overseas centre.
What a records-based follow-up review can and cannot answer
A records-based review is a way to get an opinion on your history without travelling first. It can help a haematologist understand what treatment you received, how you responded and what has been monitored since. It cannot establish that you are in remission, that a particular scan is needed now, or that a hospital will accept you for ongoing care. Those are clinical and administrative decisions for the treating team.
The most useful records for this kind of review are usually the ones that show change over time: the original diagnostic pathology, imaging reports at diagnosis and at the end of treatment, and the most recent imaging and blood results. A single scan without the earlier comparison is much less informative.
If some records are missing, that does not mean you must delay assessment. It means the review has limits, and the clinician should be told which documents are unavailable so they can say whether the gap matters. Ask specifically: 'Given what is missing, what can you conclude and what would you need to see to be more certain?'
Questions about surveillance scans after Hodgkin lymphoma treatment
Surveillance after Hodgkin lymphoma treatment is not identical for every patient. The interval and type of imaging, and how long surveillance continues, depend on the stage, the treatment given, the response achieved and the treating team's protocol. There is no single schedule that applies to everyone, and a guide cannot tell you what your schedule should be.
What you can do is prepare the information a clinician needs to answer that question for you. Bring the end-of-treatment imaging report and the most recent scan, with dates. Bring a short written summary of the treatment you received, including whether radiotherapy was part of it, because that affects which late effects are relevant to monitor.
Then ask the receiving team directly: 'Based on my history, what surveillance do you recommend, how often, and what would change that plan?' If you are already under surveillance elsewhere, ask how the China-based plan would align with the schedule you are already following. Do not stop or change an existing surveillance plan on the basis of an enquiry.
Sequencing specialists when more than one department is involved
Hodgkin lymphoma follow-up sometimes involves more than one specialty. A haematologist may lead, but questions about thyroid function after neck radiotherapy, cardiac function after certain chemotherapy, or fertility and endocrine issues may sit with other departments. The order in which you see them matters, because one opinion shapes the next question. If a cardiology assessment is arranged before the haematology review, for example, the haematologist may later want to revisit the surveillance plan in light of what the cardiac testing showed.
A practical approach is to ask the receiving hospital which specialty should see you first and whether a combined review is appropriate for your history. If a multidisciplinary review is arranged, ask what it will cover, which specialties will take part and what records each specialist needs. Ask, too, who will coordinate the conclusions into one written plan, because separate clinic letters can leave you holding three opinions and no single recommendation.
The sequencing question is not only about order. It is also about which decisions depend on which results. A thyroid function check after neck radiotherapy may be a straightforward blood test, while a cardiac review may need an echocardiogram or another test that takes time to arrange. Ask the hospital which of these can be completed during a short visit and which would need a longer stay or a separate trip.
If you are planning a short visit, ask whether the specialists you need can be scheduled within your stay or whether some questions are better handled by a records-based opinion before you travel. That is an administrative question for the coordinating team and the hospital, not something to guess.
One further distinction matters when several departments are involved: not every long-term question needs a specialist appointment. Some can be answered from records alone, and some are better raised with the clinician who will carry out the monitoring at home. Ask the receiving team to separate the questions that need an in-person assessment from those that do not, so your time and travel are spent on the parts that genuinely require them.
Planning the handover back to your local clinician
The consultation itself is only part of the task. The handover afterwards is where plans often lose their usefulness. If you return home with a verbal plan and no written summary, your local clinician may be unable to act on it.
Before you leave, ask what written documentation you will receive: a clinic letter, an imaging report, a proposed surveillance schedule, or a summary of recommendations. Ask whether it will be in English and whether it can be sent to your local doctor directly. These are questions to confirm with the specific hospital, because documentation practices differ.
It also helps to decide in advance who holds the master record. If scans are done in China and follow-up happens elsewhere, your local team needs the images and reports, not just a summary. Ask how images will be provided and in what format.
One administrative example: if your local clinician has proposed a surveillance interval and the China review suggests a different one, ask both sides to explain their reasoning in writing. You are then in a position to discuss it with the clinician who will actually carry out the follow-up, rather than choosing between two verbal opinions.
What to send first and what to ask the receiving team
You do not need to send a complete medical archive to start. A brief summary is enough for an initial enquiry: the confirmed diagnosis if known, the treatment received, the date of the most recent scan and the specific question you want answered. Records can be shared after first contact, once the team has told you what is relevant.
The questions worth putting in writing are the ones that change your decision. What surveillance does this team recommend for my history? Which records are essential and which are optional? Will I receive a written plan I can give my local doctor? If a review is arranged, what will it cover and what are its limits?
For general information on lymphoma treatment pathways in China, see the lymphoma treatment reference. If you want to understand what a records-based review involves before committing to travel, the free initial case review checks your available diagnosis, records and main question, identifies what is missing and suggests a relevant next step. It is not a diagnosis or a promise of acceptance, and it does not commit you to buying a proxy consultation.
If you have new or worsening symptoms, those take priority over any overseas planning. Seek local medical assessment first.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.